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The proteobacterial antimicrobial compound efﬂux (PACE) family of transport proteins was only recently
described. PACE family transport proteins can confer resistance to a range of biocides used as disinfec-
tants and antiseptics, and are encoded by many important Gram-negative human pathogens. However,
we are only just beginning to appreciate the range of functions and the mechanism(s) of transport
operating in these proteins. Genes encoding PACE family proteins are typically conserved in the core
genomes of bacterial species rather than on recently acquired mobile genetic elements, suggesting that
they confer important core functions in addition to biocide resistance. Three-dimensional structural
information is not yet available for PACE family proteins. However, PACE proteins have several very
highly conserved amino acid sequence motifs that are likely to be important for substrate transport. PACE
proteins also display strong amino acid sequence conservation between their Ne and C-terminal halves,
suggesting that they evolved by duplication of an ancestral protein comprised of two transmembrane
helices. In light of their drug resistance functions in Gram-negative pathogens, PACE proteins should be
the subject of detailed future investigation.
© 2018 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
In the broadest sense, drug resistance may arise in actively
growing bacterial cells in two distinct ways: either the drug target
site is protected from the toxic activities of the drug bymodiﬁcation
or bypass, or the drug cannot reach the target site due to degra-
dation, sequestration, reduced cellular entry or active efﬂux. Efﬂux
is a major mechanism of drug resistance, and due to the high
promiscuity in substrate recognition by the transport proteins
involved, efﬂux-mediated resistance is found for a wide range of
different antimicrobial compounds.
Drug efﬂux proteins from ﬁve distinct families of transport pro-
teins were described between the 1970s and 2000, and have been
studied extensively at both the functional and structural levels [1].d Life Sciences, University of
A. Hassan).
vier Masson SAS on behalf of InThese families include the ATP-binding cassette (ABC) superfamily,
the major facilitator superfamily (MFS), the resistance-nodulation-
cell division (RND) superfamily, the multidrug/oligosaccharidyl-
lipid/polysaccharide (MOP) ﬂippase superfamily and the drug/
metabolite transporter (DMT) superfamily. In the last ﬁve years two
new transporter families that include bacterial drug efﬂux systems
have been identiﬁed; these are the proteobacterial antimicrobial
compound efﬂux (PACE) family and the p-aminobenzoyl-glutamate
transporter (AbgT) family [2e4]. Proteins from the PACE family
transport biocides such as chlorhexidine and acriﬂavine, whereas
AbgT family transporters transport sulphonamides.2. The Acinetobacter baumannii AceI protein is a prototype
for the novel PACE family of transport proteins
Drug efﬂux systems, and drug resistance factors in general, are
frequently controlled by regulators that sense the transported drugstitut Pasteur. This is an open access article under the CC BY license (http://
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controls expression of the tetB tetracycline transporter gene in
response to tetracyclines, and QacR controls expression of the
multidrug efﬂux pump gene qacA in response to cationic antimi-
crobials [5]. For bacterial cells, this regulatory control means that
efﬂux pump gene expression will proceed only when the pumps
are required, saving cellular resources and preventing the potential
toxic effects of constitutive high-level efﬂux pump expression [6].
From a research perspective, this tight regulatory control of drug
efﬂux pump genes means that transcriptional changes may be used
to identify either efﬂux pumps that might recognise substrates of
interest, or novel factors that may be involved in drug resistance or
tolerance.
The Acinetobacter chlorhexidine efﬂux protein (AceI) was iden-
tiﬁed by analysing the transcriptomic response of A. baumannii to
the membrane active biocide chlorhexidine [2,7]. A. baumannii has
recently emerged as major cause of Gram-negative infections in
hospitals. Strains of A. baumannii are becoming increasingly resis-
tant to antibiotics. Consequently, carbapenem-resistant strains of
A. baumannii are listed as “Priority 1: CRITICAL” targets for devel-
opment of new antibiotics World Health Organisation [8]. Chlor-
hexidine is listed as an essential medicine by the World Health
Organisation, and is commonly used as an antiseptic in wound
dressings, hand washes and mouthwashes. The transcriptome of
A. baumannii ATCC 17978 cells exposed to a subinhibitory con-
centration of chlorhexidine, equivalent to half the minimum
inhibitory concentration, was compared to control cells. The major
gene expression changes were to genes encoding the AdeAB com-
ponents of the AdeABC multidrug efﬂux pump and a gene anno-
tated as encoding a hypothetical protein, A1S_2063 [2].
From its sequence, the A1S_2063 gene was predicted to encode
an inner membrane protein with four transmembrane helices
(Fig. 1A). The gene was cloned into an Escherichia coli expression
vector and was shown to confer signiﬁcant levels of resistance to
chlorhexidine when overexpressed in E. coli. Deletion of the
A1S_2063 gene in A. baumannii ATCC 17978 and its orthologue in
Acinetobacter baylyi ADP1 halved the chlorhexidine resistance in
the host strain, demonstrating that the genes had a resistance
function in native hosts [2,9]. The Biolog Phenotype Microarray
system was used to screen over 200 additional antimicrobials
against A1S_2063 expressing E. coli. This analysis demonstrated no
signiﬁcant hits apart from chlorhexidine, suggesting that chlor-
hexidine had an apparent speciﬁcity as a substrate [2].
When overexpressed in E. coli, the A1S_2063 protein was
identiﬁed in the inner membrane. The protein could be readily
extracted from the membrane by detergent solubilisation and pu-
riﬁed. The detergent-solubilised protein bound to chlorhexidine
with high afﬁnity (Kd in the low mM range) as determined by
tryptophan ﬂuorescence quenching and near-UV synchrotron ra-
diation circular dichroism [2]. Transport experiments using [14C]-
chlorhexidine demonstrated that the A1S_2063 protein prevented
the high-level accumulation of chlorhexidine when expressed in
E. coli until the proton-motive-force across the membrane was
collapsed using a protonophore. The protein could also mediate the
efﬂux of chlorhexidine from E. coli cells preloaded with chlorhexi-
dine [2]. Together, these results suggested that the A1S_2063 pro-
tein was a novel chlorhexidine efﬂux protein and that transport is
likely to be proton-coupled. The protein was named AceI (Acine-
tobacter chlorhexidine efﬂux protein I).
3. PACE proteins are a family of multidrug efﬂux systems
conserved across many Gram-negative pathogens
Genes encoding proteins homologous to AceI are found in the
genomes of many bacterial species, including pathogens such asPseudomonas, Klebsiella, Enterobacter, Salmonella and Burkholderia
species. These genes are particularly common among Proteobacteria,
but can be found in some Actinobacteria and in a limited number of
other unrelated bacterial species. To determine whether, like AceI,
these proteins can mediate chlorhexidine resistance, more than 20
phylogenetically diverse homologues were cloned into an E. coli
expression system and examined by routine minimum inhibitory
concentration analyses. Most of the cloned proteins were expressed
at detectable levels, and about half could confer resistance to chlor-
hexidine [3]. Notably, at least two of the aceI homologues found to
confer chlorhexidine resistance are also highly expressed in their
native hosts, Pseudomonas aeruginosa and Burkholderia cenocepacia,
in response to a chlorhexidine treatment [10,11].
Additional resistance tests were performed to determinewhether
the antimicrobial recognition proﬁles of these homologues might
extend beyond chlorhexidine. Many of the proteins were able to
confer resistance to several additional biocides, including acriﬂavine,
proﬂavine, benzalkonium and dequalinium [3]. The substrate proﬁle
of one pump, VP1155 encoded by Vibrio parahaemolyticus, was
investigated using the Biolog phenotype microarray system. In
addition to chlorhexidine, benzalkonium, proﬂavine and acriﬂavine,
VP1155 appeared to confer resistance to 9-aminoacridine, domiphen
bromide, guanazole and plumbagin [3].
The demonstration that many AceI homologues are able to confer
resistance to compounds such as proﬂavine and acriﬂavine pre-
sented the possibility of assaying transport by measuring their
ﬂuorescence in real time [12]. These compounds intercalate into
nucleic acids, which leads to a quenching of their ﬂuorescence. This
property facilitates a convenient assay for their transport in cells
expressing an efﬂux pump [13]. Cells expressing the protein of in-
terest can be loaded with proﬂavine or acriﬂavine in the presence of
a protonophore, such as carbonyl cyanidem-chlorophenylhydrazone
(CCCP), then washed and re-energised by the addition of an energy
source such as D-glucose. Fluorescence can be monitored before and
after energisation to examine transport [12]. These transport ex-
periments have been performed for a number of AceI homologues
and identiﬁed proteins that mediate transport of these compounds.
For example, the B. cenocepacia HI2424 homologue Bcen2424_2356
is able to transport acriﬂavine, whereas at least one other homo-
logue encoded by this strain, Bcen2424_5347, does not (Fig. 2).
Bcen2424_2356 has been previously shown to confer resistance to
chlorhexidine, benzalkonium, proﬂavine and acriﬂavine. The Biolog
phenotype microarray antimicrobial resistance tests conﬁrmed
several of these phenotypes and suggested that Bcen2424_2356 also
confers resistance to benzethonium, 9-aminoacridine, methyl viol-
ogen, guanazole and plumbagin (Supplemental Fig. S2).
The observation that several AceI homologues can confer
resistance to multiple biocides and can mediate transport of the
ﬂuorescent substrates proﬂavine and acriﬂavine led to their
designation as a new family of efﬂux pumps. This family was called
the Proteobacterial Antimicrobial Compound Efﬂux (PACE) family,
due to their abundance in Proteobacteria [3]. To date at least ten
putative substrates have been identiﬁed for PACE family proteins
(Fig. S3). Proteins from this family have been incorporated into the
Transporter Classiﬁcation Database [14] under the original family
title, the proteobacterial chlorhexidine efﬂux (CHX) family (TCDB
number: 2.A.117), and are captured in the TransportDB 2.0 database
[15], which catalogues all putative transport proteins from
sequenced genomes in the NCBI RefSeq database.
4. Predicted topology and sequence conservation in PACE
pumps
All PACE family proteins analysed to date are predicted to
contain four transmembrane a-helices, organised into two tandem
Fig. 1. Predicted transmembrane topology and conserved amino acid sequence motifs present in PACE family proteins. An amino acid sequence alignment of 47 diverse PACE family
proteins (Supplemental Fig. S1), encoded by a broad range of hosts, was used to identify amino acid sequence motifs that are conserved across the family (A) Predicted topology of
PACE family proteins. Upper case characters are conserved in greater than 90% of protein sequences and characters in lower case are conserved in greater than 65% but fewer than
90% of the aligned protein sequences. Conserved residues are coloured (red: negatively charged, blue: positively charged, orange: aromatic, black: others). The similar amino acid
sequence motifs in helices 1 and 3 (1A and 1B, respectively) are surrounded by purple lines, and the similar sequence motifs in helices 2 and 4 (2A and 2B, respectively) are
surrounded by green lines (BeE) Sequence logos, made using WebLogo 3 [24], showing conservation of amino acid residues in the four sequence motifs identiﬁed in PACE proteins;
error bars show an approximate Bayesian 95% conﬁdence interval [24]. (For interpretation of the references to color/colour in this ﬁgure legend, the reader is referred to the Web
version of this article.)
Fig. 2. Acriﬂavine transport mediated by PACE family proteins encoded by the human pathogen Burkholderia cenocepacia HI2424. A) Transport experiments performed using E. coli
OmniMax cells expressing the proteins of interest, essentially as described previously [3]. The cells were preloaded with 5 mM acriﬂavine in the presence of 10 mM CCCP. The cells
were washed and re-energised using glucose at the point marked with an arrow and transport monitored ﬂuorimetrically. Acriﬂavine ﬂuorescence is quenched when it is
intercalated into nucleic acids. Therefore, its transport out of the cell is associated with an increase in ﬂuorescence. B) Western blot performed on the cells used in the assay, probed
using His-Probe-HRP. The B. cenocepacia HI2424 PACE family proteins Bcen2424_2356 and Bcen2424_5347 were expressed at easily detectable levels after the 1-h induction used
for this assay. Bcen2424_2356 promoted the rapid efﬂux of acriﬂavine, whereas Bcen2424_5347 did not promote acriﬂavine transport above background. The third PACE family
protein encoded by B. cenocepacia HI2424, Bcen2424_5167 was not expressed and was excluded from the ﬁgure. Bcen2424_5167 and Bcen2424_5347 are phylogenetically distinct
from Bcen2424_2356. Error bars show the standard deviation of three replicate experiments.
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PF05232) [16]. Given their small size, it seems very likely that PACE
proteins function as oligomers. However, the oligomeric state of
PACE family proteins remains unresolved. Several PACE family
proteins have been experimentally characterised by overexpressionand puriﬁcation (Henderson et al., unpublished). When expressed
in E. coli, these proteins localise to the inner membrane and can be
readily puriﬁed by extraction with a mild detergent such as n-
dodecyl-b-D-maltoside [2], or using a styrene maleic acid co-
polymer (Supplemental Fig. S4) [17]. Analysis of the puriﬁed
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conﬁrmed their high a-helical content and demonstrated that they
typically show structural stability to around 50e60 C [2].
A high level of amino acid sequence conservation is apparent
between members of the PACE family. Based on an alignment of 47
diverse PACE family proteins from a variety of bacterial genera
(Supplemental Fig. S1), four amino acid residues appear to be
universally conserved across these proteins: a glutamic acid residue
within transmembrane helix 1, an asparagine residue in trans-
membrane helix 2, an alanine residue at the periplasmicmembrane
boundary of transmembrane helix 4 and an aspartic acid residue at
the cytoplasmic membrane boundary of transmembrane helix 4
(Fig. 1A). The functional importance of the conserved asparagine,
alanine and aspartic acid residues has not yet been investigated, but
neutralisation of the glutamic acid residue in the prototypical PACE
family member AceI by substitution with a glutamine abolished
chlorhexidine resistance and transport [2]. This mutant (E15Q) was
still able to bind chlorhexidine with only slightly reduced afﬁnity
compared to the parental protein. Furthermore, the mutant protein
was less thermostable than the parental protein in the absence of
chlorhexidine, but was signiﬁcantly more stable than the parental
protein in the presence of a molar excess of chlorhexidine, sup-
porting a binding interaction. These results suggest that the glu-
tamic acid residue is not required for substrate binding. The high
conservation of this residue in PACE proteins that have different
substrate speciﬁcities suggests that it may be involved in an aspect
of transport common to these proteins, such as an energy coupling
reaction. The position of this residue within the transmembrane
region is consistent with this possibility. In other efﬂux pumps from
the MFS, SMR and MATE families, membrane embedded carboxyl
residues participate in coupling reactions [18e20].
PACE family proteins contain several highly conserved amino
acid residues in addition to the four universally conserved residues.
The amino acid sequence conservation is particularly strong close
to the predicted cytoplasmic boundaries of the transmembrane
helices, where four amino acid sequence motifs have been identi-
ﬁed (Fig. 1). In line with the PACE proteins containing tandem BTP
domains, the amino acid sequence motif in transmembrane helix 1
(motif 1A; RxxhaxxfE, where upper case residues are conserved in
more than 90% of proteins and lower case residues in at least 65% of
proteins) is very similar to that in transmembrane helix 3 (motif 1B;
RxxHaxxFe) (Fig. 1B and C), and themotif in transmembrane helix 2
(motif 2A, WNxxy/fNxxFd) is very similar to that in transmembrane
helix 4 (motif 2B; Ytxxf/ynwxyD) (Fig. 1D and E). The notable fea-
tures of the sequence motifs in helices 1 and 3 are the membrane-
embedded glutamate residue (universally conserved in helix 1),
and histidine and arginine residues at the membrane boundary.
The motifs found in helices 2 and 4 notably contain several aro-
matic residues along one helical face adjacent to polar asparagine
residues, and an aspartate residue at the membrane boundary
(universally conserved in helix 4) (Fig. 1A).
Based on the distribution of charged residues within the loop
regions, the Ne and C-termini of most PACE family proteins are
predicted to lie within the cytoplasm, but this is yet to be
experimentally tested (Fig. 1). Some PACE family homologues,
primarily from Acetobacter, contain predicted N-terminal signal
sequences, suggesting that the N-terminus is moved across the
cytoplasmic membrane and that they may exist in an alternative
topology, e.g. APA01_04520 and APO_1949 from Acinetobacter
pasteurianus IFO 3283-01 and Acinetobacter pomorum DM001,
respectively. Representatives of these proteins have been
expressed in E. coli, but as yet, no resistance or transport functions
have been identiﬁed (Hassan et al., unpublished). These proteins
may be part of a separate protein subfamily from those that
mediate drug resistance.5. Conservation of PACE family genes
PACE family proteins are typically highly conserved in the
genome of the bacterial species in which they are found. For
example, genes encoding three different PACE proteins have been
identiﬁed in the A. baumannii pan-genome (based on the genomes
of 623 strains) [7]. Of these, two were conserved in 100% or close to
100% of the strains and can be considered to be part of the core
genome. The third gene was found in only two strains and is part of
the accessory genome. Similar to A. baumannii, P. aeruginosa iso-
lates have two PACE proteins encoded in the core genome and one
in the accessory genome, which is found in only a few strains, and
B. cenocepacia strains encode three PACE pumps in their core
genome [7]. This high level of conservation suggests that PACE
pumps are acquired vertically and have been maintained in their
host species since their divergence from related organisms. They
are thus likely to have an important core function that may be
unrelated to drug resistance. Indeed, the biocides that are recog-
nised by PACE family pumps have only been present in the envi-
ronment for 50e100 years, and are therefore very unlikely to be the
physiological substrates of these proteins.
In contrast to the species described above, E. coli do not encode
PACE pumps in their core genomes; four different genes encoding
PACE homologues were found among the genomes of 1986
sequenced E. coli strains, but these were each found in 0.2% of
strains or less [7]. These accessory genes are likely tomove between
related species onmobile genetic elements. However, there is as yet
no strong evidence for how these genes are mobilised.
6. Evolution of the PACE family
The conservation of sequence motifs between the Ne and C-
terminal halves of PACE proteins suggests that these proteins may
have evolved by a duplication event of an ancestral single BTP
domain protein. To investigate this further, the Ne and C-terminal
BTP domains were compared between 47 diverse PACE family
proteins (Supplemental Fig. S5). The level of amino acid identity
between the Ne and C-terminal BTP domains in these proteins
ranged from 6.6% to 33.3% (mean 23.3%). The presence of such high
levels of sequence identity between the Ne and C-terminal BTP
domains across diverse PACE family proteins suggests that these
proteins may not have diverged signiﬁcantly since the occurrence
of the duplication event(s). Along with the distribution of these
proteins almost exclusively within the Proteobacteria, and their
likely vertical acquisition, due to their presence on the core
genome, this may suggest that this protein family is relatively
young compared to other families of transport proteins, which
show lower levels of sequence conservation between domains that
are thought to have arisen via duplication [21].
To further examine the evolution of PACE family proteins, the
levels of sequence identity between the N-terminal and C-ter-
minal BTP domains of different PACE proteins were determined. It
was found that the N-terminal BTP domains of PACE family pro-
teins almost always have higher identity to the N-terminal BTP
domains of other PACE proteins than they do to their own C-ter-
minal BTP domain, or the C-terminal BTP domain of other PACE
family pumps (Supplemental Fig. S5). This suggests that a BTP
domain duplication event occurred only once in an ancestral gene,
and that there is little or no recombination between the Ne and C-
terminal BTP domains in individual strains. The C-terminal BTP
domains of different PACE pumps typically show even higher
levels of sequence identity than the N-terminal domains
(Supplemental Fig. S5). The high conservation of sequence within
the C-terminal domain of different proteins may reﬂect the
involvement of the C-terminal domain in a core part of the
K.A. Hassan et al. / Research in Microbiology 169 (2018) 450e454454functional mechanism, whereas the N-terminal domain may play
a bigger role in substrate recognition.
7. Concluding remarks
The PACE family of transport proteins is one of two transporter
families discovered only recently to mediate drug efﬂux. From
currently available analyses, PACE family proteins display some-
what restricted drug substrate recognition proﬁles, which include
primarily synthetic biocides such as chlorhexidine and acriﬂavine,
rather than the multitudes of diverse antibiotics and biocides
recognised by transport proteins from families such as the RND
superfamily. This may be a primary reason for the family being
only recently identiﬁed, 15 years after the ﬁrst descriptions of
MATE family pumps [22,23]. However, PACE proteins are highly
conserved in a range of opportunistic Gram-negative pathogens,
including A. baumannii, P. aeruginosa, B. cenocepacia and Klebsiella
pneumoniae, and in serious human pathogens such as Yersinia
pestis, Francisella tularensis and Burkholderia pseudomallei. There-
fore, the role of these proteins in drug resistance warrants future
investigation.
As mentioned above, the drug recognition proﬁle of PACE
pumps primarily includes synthetic biocides, most of which have
only been in the environment for 50e100 years. However, genes
encoding homologous PACE family proteins are found in the core
genomes of bacterial genera that diverged much earlier than this,
hundreds of millions of years ago. Therefore, these proteins are
likely to mediate an important core function and may have com-
mon physiological substrates that are yet to be described. The
importance of PACE family proteins is likely to extend beyond an
apparently fortuitous role in drug resistance.
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